Morphine Sulfate Extended Release

66,166 adverse event reports submitted to the FDA (1999–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Morphine Sulfate Extended Release in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Morphine Sulfate Extended Release adverse event reports by reporter sex
SexReports
Female33,972
Male26,066
Unknown219

By Age Group

View age group data as a table
Morphine Sulfate Extended Release adverse event reports by reporter age group
Age groupReports
0-171,160
18-343,374
35-496,943
50-6411,862
65-747,185
75+5,366

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Morphine Sulfate Extended Release. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Morphine Sulfate Extended Release adverse event reports by reported outcome
OutcomeReports
Other Serious36,117
Hospitalization16,074
Non-Serious15,214
Death11,763
Disability3,342
Life-Threatening2,817

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Morphine Sulfate Extended Release. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Morphine Sulfate Extended Release adverse event reports by year
YearReports
19993
20041,244
20051,048
2006952
2007529
2008649
2009697
2010892
20111,191
20121,837
20131,471
20141,867
20152,356
20162,908
20172,710
20185,587
20194,349
20203,818
20217,862
20228,450
20238,187
20243,554
20253,324
2026 (partial)681

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Morphine Sulfate Extended Release

In FDA adverse event reports that mention Morphine Sulfate Extended Release, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026